Kate Paalandi Kuhrt

Kate Paalandi Kuhrt has a diverse work experience in the fields of business development, market analysis, and portfolio commercialization. Their most recent role is as the Business Development and Market Analysis Manager at Martin's Point Health Care, a position they have held since April 2022.

Prior to this, Kuhrt worked at Clarivate as the Senior Director of Portfolio Commercialization, Science from January 2020 to December 2021. Kate also served as the Senior Director of Portfolio Commercialization, Life Sciences from January 2016 to December 2019.

Before joining Clarivate, Kuhrt held various senior roles at Thomson Reuters. Kate was the Senior Director of Life Sciences News and Generics from July 2013 to December 2015. Prior to that, they were the Senior Director of Generics and Content Strategy from June 2012 to July 2013, and the Director of Generics and API Intelligence from January 2008 to June 2012.

Kuhrt's experience in the industry began at Thomson Scientific, where they worked as the Director of Industry Research from September 2006 to December 2007. Prior to that, they served as the Manager of Industry Research from April 2004 to September 2006.

Kate also gained research experience at Newport Strategies as a Senior Researcher from February 2002 to April 2004.

Kuhrt started their career at Charles River Associates, where they held positions as an Associate from August 2000 to February 2002, and as an Analyst from August 1998 to August 2000.

Kate Paalandi Kuhrt attended Tallinna 21. keskkool from 1981 to 1993. Kate then went on to Bowdoin College, where they obtained a Bachelor's degree in Economics, graduating in 1998.

In addition to their formal education, Kate Paalandi Kuhrt has also obtained a certification in Pragmatic Marketing from Pragmatic Marketing, although the exact month and year of obtaining the certification is not provided.